Comparison of Chemokine CXCL-1 and Interleukin-6 Concentrations in the Subretinal Fluid and Vitreous in Rhegmatogenous Retinal Detachment

REFERENCES

• Yeung L, Yang KJ, Chen TL, et al. Association between severity of vitreous haemorrhage and visual outcome in primary rhegmatogenous retinal detachment. Acta Ophthalmol. 2008;86:165–169. doi:10.1111/j.1600-0420.2007.01053.x.
   PubMed Web of Science ®Google Scholar
• Pastor JC, de la Rua ER, Martin F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res. 2002;21:127–144.
   PubMed Web of Science ®Google Scholar
• Casaroli R, Vilaro S. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferativevitreoretinopathy. Invest Ophthalmol Vis Sci. 1994;35:2791.
   PubMed Web of Science ®Google Scholar
• Hiscott P, Sheridan C, Magee RM, et al. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res. 1999;18:167–190.
   PubMed Web of Science ®Google Scholar
• Charteris DG. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol. 1995;79:953–960. doi:10.1136/bjo.79.10.953.
   PubMed Web of Science ®Google Scholar
• Toti P, Greco G, Catella AM. Morphological and pathogenetic aspects of proliferative vitreo-retinopathy. Doc Ophthalmol. 1994;88:105–112. doi:10.1007/bf01204608.
   PubMed Web of Science ®Google Scholar
• Fisher S, Erickson P, Lewis G, Anderson D. Intraretinal proliferation induced by retinal detachment. Invest Ophthalmol Vis Sci. 1991;32:1739–1748.
   PubMed Web of Science ®Google Scholar
• Nagasaki H, Shinagawa K, Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res. 1998;17:77–98.
   PubMed Web of Science ®Google Scholar
• Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy and retinal degeneration. Surv Ophthalmol. 1992;36:373–384. doi:10.1016/0039-6257(92)90115-a.
   PubMed Web of Science ®Google Scholar
• Borish LC, Steinke JW. 2. Cytokines and chemokines. J Allergy Clin Immunol. 2003;111:S460–475. doi:10.1067/mai.2003.108.
   PubMedGoogle Scholar
• Sharma M. Chemokines and their receptors: orchestrating a fine balance between health and disease. Crit Rev Biotechnol. 2010;30:1–22. doi:10.1080/07388550903187418.
   PubMed Web of Science ®Google Scholar
• Vandercappellen J, Van Damme J, Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett. 2008;267:226–244. doi:10.1016/j.canlet.2008.04.050.
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Loetscher P, Moser B. Interleukin-8 and the chemokine family. Int J Immunopharmacol. 1995;17:103–108. doi:10.1016/0192-0561(94)00088-6.
   PubMed Web of Science ®Google Scholar
• Tojo N, Kashiwagi Y, Nishitsuka K, et al. Interactions between vitreous-derived cells and vascular endothelial cells in vitreoretinal diseases. Acta Ophthalmol. 2010;88:564–570. doi:10.1111/j.1755-3768.2008.01466.x.
   PubMed Web of Science ®Google Scholar
• Symeonidis C, Androudi S, Rotsos T, et al. Chemokine CXCL-1 expression in the subretinal fluid during rhegmatogenous retinal detachment. Ocul Immunol Inflamm. 2014;22:449–453. doi:10.3109/09273948.2013.863942.
   PubMed Web of Science ®Google Scholar
• Symeonidis C, Androudi S, Georgalas I, et al. Chemokine CXCL-1: activity in the vitreous during proliferative vitreoretinopathy. Clin Exp Immunol. 2015;181:338–342. doi:10.1111/cei.12627.
   PubMed Web of Science ®Google Scholar
• La Heij EC, Van De Waarenburg MP, Blaauwgeers HG, et al. Levels of basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in subretinal fluid from patients with retinal detachment. Am J Ophthalmol. 2001;132:544–550. doi:10.1016/s0002-9394(01)01125-4.
   PubMed Web of Science ®Google Scholar
• La Heij EC, van de Waarenburg MP, Blaauwgeers HG, et al. Basic fibroblast growth factor,glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy. Am J Ophthalmol. 2002;134:367–375. doi:10.1016/s0002-9394(02)01536-2.
   PubMed Web of Science ®Google Scholar
• Takeuchi A, Kricorian G, Marmor MF. When vitreous enters the subretinal space. Implications for subretinal fluid protein. Retina. 1996;16:426–430. doi:10.1097/00006982-199616050-00010.
   PubMed Web of Science ®Google Scholar
• Kopf M, Baumann H, Freer G, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 1994;368:339–342. doi:10.1038/368339a0.
   PubMed Web of Science ®Google Scholar
• Campbell SJ, Hughes PM, Iredale JP, et al. CINC-1 is identified as an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. Faseb J. 2003;17:1168–1170. doi:10.1096/fj.02-0757fje.
   PubMed Web of Science ®Google Scholar
• Campbell SJ, Perry VH, Pitossi FJ, et al. Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am J Pathol. 2005;166:1487–1497. doi:10.1016/S0002-9440(10)62365-6.
   PubMed Web of Science ®Google Scholar
• Liu J, Shi B, He S, et al. Changes to tear cytokines of type 2 diabetic patients with or without retinopathy. Mol Vis. 2010;16:2931–2938.
   PubMed Web of Science ®Google Scholar
• Zhou JM, Ye Q. Utility of assessing cytokine levels for the differential diagnosis of pneumonia in a pediatric population. Pediatr Crit Care Med. 2017;18:e162–e166. doi:10.1097/PCC.0000000000001092.
   PubMed Web of Science ®Google Scholar
• Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983;90:121–125..
   Web of Science ®Google Scholar
• Plantner JJ, Jiang C, Smine A. Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp Eye Res. 1998;67:637–645. doi:10.1006/exer.1998.0552.
   PubMed Web of Science ®Google Scholar
• Song M, Kellum JA. Interleukin-6. Crit Care Med. 2005;33:S463. doi:10.1097/01.CCM.0000186784.62662.A1.
   PubMedGoogle Scholar
• Nakahara H, Song J, Sugimoto M, et al. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum. 2003;48:1521–1529. doi:10.1002/art.11143.
   PubMed Web of Science ®Google Scholar
• Quintyn JC, Brasseur G. Subretinal fluid in primary rhegmatogenous retinal detachment: physiopathology and composition. Surv Ophthalmol. 2004;49:96–108. doi:10.1016/j.survophthal.2003.10.003.
   PubMed Web of Science ®Google Scholar
• Boulton M, Moriarty P, Gregor ZJ. Biological activities of vitreous gel, retrohyaloid fluid and subretinal fluid from diabetic and non-diabetic eyes. Br J Ophthalmol. 1992;76:79–83. doi:10.1136/bjo.76.2.79.
   PubMed Web of Science ®Google Scholar
• Kenarova B, Voinov L, Apostolov C, et al. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment. Eur J Ophthalmol. 1997;7:64–67.
   PubMedGoogle Scholar
• Bakunowicz-Lazarczyk A, Sulkowski S, Moniuszko T. Comparative studies of morphological changes and interleukin concentration in subretinal fluid of patients with retinal detachment. Ophthalmologica. 1999;213:25–29. doi:10.1159/000027389.
   PubMed Web of Science ®Google Scholar
• Ricker LJ, Kijlstra A, de Jager W, et al. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment. Invest Ophthalmol Vis Sci. 2010;51:4143–4150. doi:10.1167/iovs.09-5057.
   PubMed Web of Science ®Google Scholar
• Spandau UH, Toksoy A, Verhaart S, et al. High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. Arch Ophthalmol. 2003;121:825–831. doi:10.1001/archopht.121.6.825.
   PubMed Web of Science ®Google Scholar
• Losy J, Zaremba J, Skrobanski P. CXCL1 (GRO-alpha) chemokine in acute ischaemic stroke patients. Folia Neuropathol. 2005;43:97–102.
   PubMed Web of Science ®Google Scholar
• Symeonidis C, Androudi S, Tsaousis KT, et al. Comparison of interleukin IL-6 levels in the subretinal fluid and the vitreous during rhegmatogenous retinal detachment. Cytokine. 2012;57:17–18. doi:10.1016/j.cyto.2011.09.019.
   PubMed Web of Science ®Google Scholar